Phillip Kang

Phillip Kang, PhD, currently serves as the Head of Commercial Analytics at Impiricus, beginning in April 2024. Previously, from June 2022 to April 2024, Phillip was the Head of Sponsor Adoption & Commercialization at Care Access, where responsibilities included driving business development strategy, managing pipeline analyses, and supporting large project proposals. Phillip also held the role of Director, Strategy and Operations at Care Access, where leadership focused on Go-To-Market strategy and financial modeling. Prior experience includes positions at Boston Consulting Group as a Project Leader and Consultant, and extensive research roles during academic tenure at the University of California, Berkeley, and the University of Maryland School of Medicine, with a focus on bioengineering, stem cell differentiation, and immunology. Phillip earned dual PhDs in Bioengineering and Biomedical Engineering from the University of California, Berkeley and the University of California, San Francisco, as well as a Bachelor of Science in Chemical Engineering from the University of Maryland Baltimore County.